UnknownNot Applicable

Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers

Thailand150 participantsStarted 2024-03-26

Plain-language summary

A randomized controlled trial to evaluate the efficacy of hemostatic forceps and bipolar electrocautery probes in patient with high risk bleeding gastroduodenal ulcers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The patient with upper gastrointestinal hemorrhage age ≥ 18 years old
✓. The patient with gastroduodenal ulcer with indication for hemostatic intervention including 2.1 Forrest classification 1a (Active spurting) 2.2 Forrest classification 1b (Active oozing) 2.3 Forrest classification 2a (Non-bleeding visible vessel; NBVV) 2.4 Forrest classification 2b (Adherent clot) with lesion underneath clot which need hemostatic intervention including active spurting, active oozing or non-bleeding visible vessel

Exclusion criteria

✕. Uncorrectable hemostasis laboratory including serum platelet \< 50000 /mm3 or International Normalized Ratio (INR) \>1.5
✕. Bleeding from cancerous gastroduodenal ulcer
✕. The patient with history of gastric surgery
✕. The patient with history of bleeding gastroduodenal ulcer within 30 days prior to enrollment
✕. The patient with history of proton pump inhibitor allergy
✕. Pregnant
✕. The patient deny to participate in the study

What they're measuring

Comparing hemostatic rate between hemostatic forceps and bipolar electrocautery probes

Timeframe: During esophagogastroduodenoscopy

Trial details

NCT IDNCT06393907

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-26

Contact for this trial

Uayporn Kaosombattwattana, MD

+66619245953 Koigi214@gmail.com

View on ClinicalTrials.gov More Gastroduodenal Ulcer trials